Treatment of Hepatitis C in HIV-Infected Patients: Moving Towards an Era of All Oral Regimens

por Chen, Ting-Yi, Jain, Mamta K.
Publicado 2015

2233. Hepatitis C Eradication: Who Is Being Left Behind in the HIV Population?

por Jain, Mamta K, Chavez, Claudia, Sanders, Joanne, Vysyaraju, Kranthi
Publicado 2018

525. Atovaquone for Treatment of COVID-19 (Ataq COVID-19) Trial

por Jain, Mamta K, Jain, Mamta K, Sadek, Hesham, de Lemos, James, mcGuire, Darren, Ayers, Colby, Eiston, Jennifer L, Lucas, Claudia, Kamel, Dena, Li, Xilong, Agbor, Barbine Agbor, Williams, Noelle, Schoggins, John
Publicado 2021

Persistent CMV pneumonitis in HIV infection: a case report

por Frederick, Abbye W., Kitchell, Ellen, McCormick-Baw, Clare, Kukkar, Vishal, Jain, Mamta K.
Publicado 2023

2207. Barriers to HCV Treatment in a Safety-Net Hospital System

por Gull, Sabhi, Quirk, Lisa, McBryde, Jennifer, Rich, Nicole, Singal, Amit, Jain, Mamta K
Publicado 2018

Predictors of linkage to hepatitis C virus care among people living with HIV with hepatitis C infection and the impact of loss to HIV follow‐up

por Lau, Abby A., Strebe, Joslyn K., Sura, Teena V., Hansen, Laura A., Jain, Mamta K.
Publicado 2022

1396. COVID-19 Hospitalization Impact of Age, Race and Ethnicity Among Medicaid and Uninsured

por Jain, Mamta K, Zhang, Yi, Thamer, Mae, Harms, Michael, Smartt, Jillian, Baierlipp, Stefanie, Bhavan, Kavita
Publicado 2022

2495. Inpatient Hepatitis C Virus Testing Increased During the COVID-19 Pandemic

por Fitzgerald, Brendan J, Jain, Mamta K, Radunsky, A L exander P, Cooper, Lauren N, Hansen, Laura
Publicado 2023

2502. Best Practice Alert for Hepatitis C Virus Screening Demonstrates Importance of Reminders during Disruptive Times (COVID-19)

por Mason, Alec R, Radunsky, A L exander P, Reyes, Stephanie M, McBryde, Jennifer, Jain, Mamta K
Publicado 2023

Incidence and Predictors of Hepatitis B Surface Antigen Clearance in HIV Patients: A Retrospective Multisite Study

por Jain, Mamta K, Vigil, Karen J, Parisot, Paul, Go, Gabriella, Vu, Trung, Li, Xilong, Hansen, Laura, Taylor, Barbara S
Publicado 2021

Who Is at Risk for New Hepatitis B Infections Among People With HIV?

por Sladic, John M, Taylor, Barbara S, Thamer, Mae, Vigil, Karen J, Kshirsagar, Onkar, Taranova, Anna, McCracken, Andrew, Sanchez, Carmen G, Jain, Mamta K
Publicado 2023

Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort

por Safo, Sandra E., Haine, Lillian, Baker, Jason, Reilly, Cavan, Duprez, Daniel, Neaton, James D., Jain, Mamta K., Arenas‐Pinto, Alejandro, Polizzotto, Mark, Staub, Therese
Publicado 2023

89976 ASSESSING PROTEIN BIOMARKERS ROLE IN CVD RISK PREDICTION IN PERSONS LIVING WITH HIV (PWH)

por Safo, Sandra, Haine, Lillian, Baker, Jason, Reilly, Cavan, Duprez, Daniel, Neaton, Jim, Wang, Jiuzhou, Jain, Mamta K., Pinto, Alejandro Arenas, Staub, Therese, Polizzotto, Mark
Publicado 2021

Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study

por Yek, Christina, de la Flor, Carolina, Marshall, John, Zoellner, Cindy, Thompson, Grace, Quirk, Lisa, Mayorga, Christian, Turner, Barbara J., Singal, Amit G., Jain, Mamta K.
Publicado 2017

Host Cell Redox Alterations Promote Latent HIV-1 Reactivation through Atypical Transcription Factor Cooperativity

por Cruz-Lorenzo, Emily, Ramirez, Nora-Guadalupe P., Lee, Jeon, Pandhe, Sonali, Wang, Lei, Hernandez-Doria, Juan, Spivak, Adam M., Planelles, Vicente, Petersen, Tianna, Jain, Mamta K., Martinez, Elisabeth D., D’Orso, Iván
Publicado 2022

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis

por Price, Huw, Dunn, David, Pillay, Deenan, Bani-Sadr, Firouze, de Vries-Sluijs, Theodora, Jain, Mamta K., Kuzushita, Noriyoshi, Mauss, Stefan, Núñez, Marina, Nüesch, Reto, Peters, Marion, Reiberger, Thomas, Stephan, Christoph, Tan, Lionel, Gilson, Richard
Publicado 2013

A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)‐HIV co‐infection with high prevalence of tenofovir‐based antiretroviral therap...

por Gizaw, Andinet, King, Wendy C., Hinerman, Amanda S., Chung, Raymond T., Lisker‐Melman, Mauricio, Ghany, Marc G., Khalili, Mandana, Jain, Mamta K., Graham, Jacob, Swift‐Scanlan, Theresa, Kleiner, David E., Sulkowski, Mark, Wong, David K., Sterling, Richard K.
Publicado 2022

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza

por Vanderven, Hillary A., Wentworth, Deborah N., Han, Win Min, Peck, Heidi, Barr, Ian G., Davey, Richard T., Beigel, John H., Dwyer, Dominic E., Jain, Mamta K., Angus, Brian, Brandt, Christian T., Mykietiuk, Analia, Law, Matthew G., Neaton, James D., Kent, Stephen J.
Publicado 2023

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens

por Huhn, Gregory D., Ramgopal, Moti, Jain, Mamta K., Hinestrosa, Federico, Asmuth, David M., Slim, Jihad, Goldstein, Deborah, Applin, Shauna, Ryu, Julie H., Jiang, Shuping, Cox, Stephanie, Das, Moupali, Nguyen-Cleary, Thai, Piontkowsky, David, Guyer, Bill, Rossaro, Lorenzo, Haubrich, Richard H.
Publicado 2020

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

por Davey, Richard T, Fernández-Cruz, Eduardo, Markowitz, Norman, Pett, Sarah, Babiker, Abdel G, Wentworth, Deborah, Khurana, Surender, Engen, Nicole, Gordin, Fred, Jain, Mamta K, Kan, Virginia, Polizzotto, Mark N, Riska, Paul, Ruxrungtham, Kiat, Temesgen, Zelalem, Lundgren, Jens, Beigel, John H, Lane, H Clifford, Neaton, James D
Publicado 2019